Percutaneous Biopsy of a Nodule Adjacent to the Aortic Arch Assisted by Artificial Pneumothorax: A Case Report and Literature ReviewJiahao Li#, Yao Dai#&,Kun Wang#,Yulong Zhu*# The Fourth Clinical Medical College of Xinjiang Medical University, Urumqi, Xinjiang, 830000, China&Chinese Medicine Hospital of Gao County, Yibin, 645150, China.* Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Urumqi, Xinjiang, 830000, ChinaCorrespondence: Yulong Zhu(XJ13319850606@sina.cn)Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.Keywords: Artificial pneumothorax; Percutaneous lung biopsy; Lung cancer;Abstract: Percutaneous biopsy of nodules adjacent to the aortic arch is challenging and risky due to the complex anatomical structures in this area. This paper reports a case of percutaneous biopsy of a nodule adjacent to the aortic arch assisted by artificial pneumothorax. The patient recovered well after the operation without severe complications. Meanwhile, a literature review was conducted to summarize the application status, advantages, and disadvantages of artificial pneumothorax-assisted techniques in percutaneous biopsy of nodules adjacent to the aortic arch. The research shows that the artificial pneumothorax-assisted technique can improve the success rate of puncture and reduce the risk of damage to surrounding important structures. However, further exploration and optimization are still needed in aspects such as the control of gas injection volume. This case and literature review provide valuable references for the clinical application of this technique and contribute to promoting its rational use in the diagnosis of thoracic diseases.IntroductionDuring lung cancer diagnosis and treatment, an accurate pathological diagnosis is crucial for effective treatment plans. Percutaneous lung biopsy, a low - trauma and low - risk diagnostic method, is widely used clinically. But for lung lesions near the aortic arch, heart, large vessels or trachea, traditional biopsies face great challenges due to complex vascular anatomy, with increased puncture difficulty and risk. In recent years, the artificial pneumothorax - assisted technique has emerged for such special - site lesions. 1By creating an artificial pneumothorax before puncture, it changes the thoracic anatomy to aid the operation. Although it has achieved some success, it’s still being explored and refined. This article reports a case of percutaneous biopsy of an aortic - arch - adjacent pulmonary nodule using this technique, analyzes the procedure, pathological results and follow - up treatment. It also reviews the technique’s application, pros and cons to guide its rational use and promote its development in thoracic disease diagnosis. This study follows the ”Strengthening the Reporting of Surgical Case Reports (SCARE) Guidelines 2023”.2Clinical DataGeneral InformationThe patient was a 60-year-old female who was admitted to the hospital due to the discovery of a shadow in the left upper lobe of the lung for 6 days. Six days ago, the patient accidentally fell off a bicycle, landing on the right side of her body. After the fall, she experienced pain in the right hypochondrium, without cough, expectoration, chest tightness, shortness of breath, dizziness, or presyncope. A pulmonary CT scan in an external hospital showed a shadow in the left upper lung, and she was recommended to seek further medical advice at a higher-level hospital. Therefore, she came to our hospital for treatment. At the time of admission, the patient had no cough, expectoration, hemoptysis, chest tightness, chest pain, or other special discomforts. Physical examination: body temperature was 36.5℃, pulse rate was 74 beats per minute, respiratory rate was 18 breaths per minute, and blood pressure was 147/87 mmHg. No enlarged superficial lymph nodes were palpable throughout the body. The lips and nails showed no cyanosis, the pharynx was not congested, and the tonsils were not enlarged. The chest was symmetric. Palpation revealed symmetric vocal fremitus on both sides of the chest. Percussion showed a resonant sound. The breath sounds of both lungs were rough, and no dry or wet rales were heard. The cardiac border was not enlarged, the rhythm was regular, and no pathological murmurs were heard in each valve auscultation area. The abdomen was soft, without tenderness. The liver and spleen were not palpable under the costal margin. There was no percussion pain in the bilateral renal areas. The spine and limbs had no deformities, and there was no edema in the bilateral lower extremities.Results of Relevant ExaminationsThe patient was admitted to our hospital on December 11, 2024. After admission, a pulmonary CT scan indicated: 1. Considered peripheral lung cancer in the left upper lobe, please combine with clinical manifestations; 2. Multiple ground-glass nodules in the left lower lobe, follow-up is recommended; 3. Reduced density of the heart cavity and large blood vessels, suggesting anemia; 4. Fibrous and calcified foci in the right upper lobe of the lung; scattered fibrotic foci in the right lung. (Figure 1) Blood gas analysis: pH: 7.42, partial pressure of carbon dioxide (PCO2) 37.10 mmHg, partial pressure of oxygen (PO2) 90.90 mmHg, oxygen saturation (SpO2) 97.20%, actual bicarbonate (AB) 23.70 mmol/L, standard base excess (SBE) -0.20 mmol/L, base excess (BE) 0.10 mmol/L, erythrocyte sedimentation rate (ESR) 24 mm/h, white blood cell count 4.39×10^9/L, lymphocyte percentage 32.8%, monocyte percentage 8%, neutrophil percentage 58%, lymphocyte absolute value 1.44×10^9/L, monocyte absolute value 0.35×10^9/L, neutrophil absolute value 2.55×10^9/L. Carcinoembryonic antigen (CEA) was 5.70 ng/ml, cytokeratin 19 fragment (CYFRA21-1) was 1.45 ng/ml, neuron-specific enolase (NSE) was 9.69 ng/ml, squamous cell carcinoma antigen (SCCA) was 0.70 ng/ml, and pro-gastrin-releasing peptide (ProGRP) was 32.25 pg/ml. No significant abnormalities were found in the four-item test for rheumatism, antinuclear antibody spectrum, immunoglobulin and complement, interleukin-6, liver and kidney function, myocardial enzyme spectrum, electrolytes, coagulation function, D-dimer, tuberculosis antibody, urine routine, C-reactive protein, procalcitonin, respiratory pathogens, GM test, tuberculosis infection T cell test, and sputum smear for acid-fast bacilli.